Health care, one of the largest and most complex sectors, have outperformed the broader market, providing investors with a total return of 16.3% compared to the S&P 500's total return of 5.9% over the past 12 months. In 2020, health care stocks have recouped nearly all of their losses since their March plunge while the broader market continues to suffer from the global coronavirus pandemic. Livongo, Amedisys, and Align are some of stocks with strong catalysts to bounce back the next time Wall Street takes a punch to the gut.
Livongo Health (NASDAQ: LVGO) Livongo Health provides a data science and technology enabled platform for detection of diabetes. Its additional solutions include Livongo for Hypertension, Livongo for Prediabetes and Weight Management, and Livongo for Behavioral Health by myStrength. The company's clients comprise of employers, health plans, government entities, and labor unions. LVGO shares are trading higher on June, potentially amid concerns of a resurgence in U.S. coronavirus cases. The coronavirus has been a positive catalyst for the digital health space. LVGO closed at $70.12 with a gain of $3.08 (4.59%). The company expects second-quarter revenue of between $73 million and $75 million. It also raised its full-year revenue guidance to a range of $290 million to $303 million. For the long-term investment, the LVGO stock price is expected to be $192.573. With a 5-year investment, the revenue is expected to be around +174.59%.
Align Technology Inc. (ALGN): Align Technology, Inc. engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner, and Scanner and Services segments. ALGN is currently trading in the percentile range relative to its historical Stock Score levels. Align Technology Inc has on average historically risen by 42% based on the past 19 years of stock performance. The current Align Technology Inc. share price is $262.21 with gain of $2.40 (0.92%). The 14 analysts offering 12-month price forecasts for Align Technology Inc have a median target of $252.50 with a high estimate of $333.00 and a low estimate of $180.00.
Amedisys Inc, NASDAQ: AMED, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. Amedisys’ hospice segment brought in $38.3 million during the first quarter of 2020, representing an increase of $4.8 million from the prior year’s quarter. Revenues for the hospice segment rose 23.1%, largely driven by the Compassionate Care acquisition, which made the company the third-largest hospice provider in the nation. Amedisys Inc (AMED) jumped $9.70 (5.39%) to close at $189.58. The 13 analysts offering 12-month price forecasts for Amedisys Inc have a median target of $214.00, with a high estimate of $240.00 and a low estimate of $190.00.
© 2000-2023. All rights reserved.
This site is managed by Teletrade D.J. LLC 2351 LLC 2022 (Euro House, Richmond Hill Road, Kingstown, VC0100, St. Vincent and the Grenadines).
The information on this website is for informational purposes only and does not constitute any investment advice.
The company does not serve or provide services to customers who are residents of the US, Canada, Iran, The Democratic People's Republic of Korea, Yemen and FATF blacklisted countries.
Making transactions on financial markets with marginal financial instruments opens up wide possibilities and allows investors who are willing to take risks to earn high profits, carrying a potentially high risk of losses at the same time. Therefore you should responsibly approach the issue of choosing the appropriate investment strategy, taking the available resources into account, before starting trading.
Use of the information: full or partial use of materials from this website must always be referenced to TeleTrade as the source of information. Use of the materials on the Internet must be accompanied by a hyperlink to teletrade.org. Automatic import of materials and information from this website is prohibited.
Please contact our PR department if you have any questions or need assistance at email@example.com.